Eagle Health Investments LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001842545

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 22 positions · Total reported value $492.13M · Top-10 concentration 75.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 4 new · 4 cut · 9 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2023 13F filing, Eagle Health Investments LP disclosed 22 equity positions with a combined reported value of $492.13M. The filing implies a focused portfolio: its ten largest positions account for 75.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were ICLR ($46.73M), ILMN ($44.38M), NTRA ($43.28M). By sector, the heaviest allocations are Health Care 88.4%, Industrials 10.5%. Versus the prior quarter, allocation shifted toward Industrials (+0.9pp) and away from Health Care (-0.9pp).

Versus the prior quarter, Eagle Health Investments LP opened 4 new positions, trimmed 4 and fully exited 9, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q4 2023 were PACB ($14.94M), IMCR ($3.16M).

Of the 9 positions fully exited versus the prior quarter, the largest were OM ($16.26M), PNT ($2.04M), CMAX ($1.52M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • PACB PACIFIC BIOSCIENCES CALIF IN · $14.94M
  • IMCR IMMUNOCORE HLDGS PLC · $3.16M

Fully Exited (vs previous quarter)

  • OM OUTSET MED INC · prev qtr: $16.26M
  • PNT POINT BIOPHARMA GLOBAL INC · prev qtr: $2.04M
  • CMAX CAREMAX INC · prev qtr: $1.52M

Insider Transactions (Form 4)

Latest Eagle Health Investments LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Eagle Health Investments LP, based in Greenwich, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 27 positions worth $603.31M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-121917 (status: Approved), registered 2021-07-29
  • Regulatory AUM (Form ADV): $605.26M as of 2026-03-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 27 positions · $603.31M reported value (Q2 2026)
  • Top 10 holdings = 66.1% of reported value
  • Largest position: ARGX (ARGENX SE FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS) at 11.8%
  • Average position size: $22.34M

Sector Tilt

  • Health Care 96.0%
  • Information Technology 2.5%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 5 new, 9 added, 4 reduced, 5 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 88.4%
Industrials 10.5%
Other 1.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 165.10K $46.73M 9.50%
9.50%
Reduce
2 318.75K $44.38M 9.02%
9.02%
Add
3 690.86K $43.28M 8.79%
8.79%
Add
4 173.59K $40.17M 8.16%
8.16%
Reduce
5 309.32K $38.38M 7.80%
7.80%
Add
6 170.84K $37.57M 7.63%
7.63%
Hold
7 157.78K $36.50M 7.42%
7.42%
Reduce
8 84.59K $32.18M 6.54%
6.54%
Add
9 136.76K $26.18M 5.32%
5.32%
Hold
10 314.86K $24.85M 5.05%
5.05%
Reduce
11 113.50K $23.09M 4.69%
4.69%
Add
12 189.36K $18.26M 3.71%
3.71%
Add
13 1.52M $14.94M 3.04%
3.04%
New
14 43.39K $14.64M 2.97%
2.97%
Hold
15 337.22K $14.13M 2.87%
2.87%
Hold
16 437.91K $8.87M 1.80%
1.80%
Hold
17 330.83K $7.37M 1.50%
1.50%
Add
18 1.21M $5.95M 1.21%
1.21%
Hold
19 579.77K $5.57M 1.13%
1.13%
Hold
20 120.11K $3.25M 0.66%
0.66%
Reduce
21 46.30K $3.16M 0.64%
0.64%
New
22 43.20K $2.68M 0.54%
0.54%
Reduce

FAQ

What did Eagle Health Investments LP buy in 2023-Q4?

In its 2023-Q4 13F filing, Eagle Health Investments LP reported 22 equity positions worth $492.13M in aggregate; its largest disclosed positions were ICLR ($46.73M), ILMN ($44.38M), NTRA ($43.28M).

How large is Eagle Health Investments LP's portfolio?

Eagle Health Investments LP reported $492.13M of long equity holdings across 22 positions as of 2023-Q4. Top-10 holdings account for 75.2% of reported value.

What is Eagle Health Investments LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eagle-health-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →